Cixutumumab (Anti-IGF1R / CD221)

製品コード：A2599        

印刷

Cixutumumab (Anti-IGF1R / CD221) is a humanized monoclonal antibody with high affinity that targets type-1-insulin-like growth factor receptor (IGF-1R).It shows broad-spectrum anti-tumour activity and can be used in studies of sarcomas, neuroblastoma, wilms tumor, lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer. MW :150 KD.

製品説明

CAS No. 947687-12-9
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。